| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/22/2022 | Kronos Bio, Inc. | KRON | Grant | Stock Option (Right to Buy) | 34k | $3.53 | $120k | | 06/22/2022 |
| 06/15/2022 | Allogene Therapeutics, Inc. | ALLO | Grant | Common Stock | 44.2k | $0.00 | $0 | | 06/15/2022 |
| 03/07/2022 | Kronos Bio, Inc. | KRON | Gift | Common Stock | 211k | $0.00 | $0 | | 03/07/2021 |
| 03/07/2022 | Allogene Therapeutics, Inc. | ALLO | Other (acquisition) | Common Stock | 412.6k | $0.00 | $0 | | 03/07/2022 |
| 03/07/2022 | Allogene Therapeutics, Inc. | ALLO | Gift | Common Stock | 412.6k | $0.00 | $0 | | 03/07/2022 |
| 01/12/2022 | Allogene Therapeutics, Inc. | ALLO | Purchase | Common Stock | 15k | $12.60 | $189k | | 01/12/2022 |
| 06/22/2021 | Kronos Bio, Inc. | KRON | Grant | Stock Option (Right to Buy) | 20.6k | $24.18 | $498.1k | | 06/22/2021 |
| 06/11/2021 | Allogene Therapeutics, Inc. | ALLO | Gift | Common Stock | 500k | $0.00 | $0 | | 06/10/2021 |
| 06/10/2021 | Allogene Therapeutics, Inc. | ALLO | Grant | Common Stock | 16.5k | $0.00 | $0 | | 06/10/2021 |
| 06/04/2021 | Latch, Inc. | | Exercise | Class B common stock | 30k | $0.00 | $0 | | 06/04/2021 |
| 02/12/2021 | Tishman Speyer Innovation Corp. II | | Purchase | | 25k | $0.00 | $0 | | 02/12/2021 |
| 02/12/2021 | Tishman Speyer Innovation Corp. II | | Purchase | | 5k | $0.00 | $0 | | 02/12/2021 |
| 10/14/2020 | Kronos Bio, Inc. | KRON | Conversion | Common Stock | 23.6k | $0.00 | $0 | | 10/14/2020 |
| 10/14/2020 | Kronos Bio, Inc. | KRON | Conversion | Common Stock | 68.8k | $0.00 | $0 | | 10/14/2020 |
| 10/14/2020 | Kronos Bio, Inc. | KRON | Conversion | Series Seed Preferred Stock | 22.3k | $0.00 | $0 | | 10/14/2020 |
| 10/14/2020 | Kronos Bio, Inc. | KRON | Conversion | Series A Preferred Stock | 65.2k | $0.00 | $0 | | 10/14/2020 |
| 06/05/2020 | Allogene Therapeutics, Inc. | ALLO | Grant | Common Stock | 10k | $0.00 | $0 | | 06/05/2020 |
| 04/24/2020 | Allogene Therapeutics, Inc. | ALLO | Other (acquisition) | Common Stock | 8k | $0.00 | $0 | | 04/24/2020 |
| 03/04/2020 | Allogene Therapeutics, Inc. | ALLO | Other (acquisition) | Common Stock | 8.2k | $0.00 | $0 | | 03/04/2020 |
| 12/31/2019 | DraftKings Holdings Inc. | DKNG | Other (acquisition) | Class B Common Stock | 20k | $0.00 | $2 | | 12/31/2019 |
| 11/19/2019 | Allogene Therapeutics, Inc. | ALLO | Other (acquisition) | Common Stock | 8.2k | $0.00 | $0 | | 11/19/2019 |
| 11/11/2019 | Allogene Therapeutics, Inc. | ALLO | Gift | Common Stock | 446.6k | $0.00 | $0 | | 11/19/2019 |
| 10/25/2019 | Allogene Therapeutics, Inc. | ALLO | Other (acquisition) | Common Stock | 8.2k | $0.00 | $0 | | 10/25/2019 |
| 09/23/2019 | Allogene Therapeutics, Inc. | ALLO | Other (acquisition) | Common Stock | 8.2k | $0.00 | $0 | | 09/23/2019 |
| 09/05/2019 | Allogene Therapeutics, Inc. | ALLO | Other (acquisition) | Common Stock | 8.2k | $0.00 | $0 | | 09/05/2019 |
| 07/18/2019 | Allogene Therapeutics, Inc. | ALLO | Other (acquisition) | Common Stock | 8.2k | $0.00 | $0 | | 07/18/2019 |
| 07/10/2019 | Allogene Therapeutics, Inc. | ALLO | Other (acquisition) | Common Stock | 5.6k | $0.00 | $0 | | 07/10/2019 |
| 06/06/2019 | Allogene Therapeutics, Inc. | ALLO | Grant | Common Stock | 16.4k | $0.00 | $0 | | 06/06/2019 |
| 03/05/2019 | Target Hospitality Corp. | TH | Purchase | Class A Ordinary Shares | 5k | $10.20 | $51k | | 03/05/2019 |
| 03/01/2019 | Target Hospitality Corp. | TH | Purchase | Class A Ordinary Shares | 5k | $10.13 | $50.6k | | 03/01/2019 |
| 01/22/2019 | Target Hospitality Corp. | TH | Purchase | Class B Ordinary Shares | 20k | $0.00 | $62 | | 01/22/2019 |
| 10/15/2018 | Allogene Therapeutics, Inc. | ALLO | Conversion | Series A Convertible Preferred Stock | 3.6k | $0.00 | $0 | | 10/15/2018 |
| 10/15/2018 | Allogene Therapeutics, Inc. | ALLO | Conversion | Common Stock | 18.7k | $0.00 | $0 | | 10/15/2018 |
| 01/17/2018 | Target Hospitality Corp. | TH | Grant | Private Placement Warrants | 333.3k | $1.50 | $500k | | 01/17/2018 |
| 01/02/2018 | CAPRICOR THERAPEUTICS, INC. | CAPR | Grant | Stock Option (right to buy) | 18k | $1.57 | $28.3k | | 01/02/2018 |
|